All funds

Goodhart Partners

Mar 2026 → Jun 2026 · 4 funds

Our archive holds 8 letters from Goodhart Partners, behind 9 investment theses and positions in 11 companies. Every quote below is copied verbatim from the letter it came from.

Goodhart Partners’s own letters page
8
Letters
11
Companies
6
Moves
9
Theses

What they bought and sold · 6 moves

  • ExitedSoitec
    June 2026
    I trimmed meaningfully and sold the remainder at EUR150 as I could no longer justify the returns within my multi-bagger framework
    Read the letter
  • TrimmedAngi
    June 2026
    Angi, -50%, a small position and subsequently sold due to a change in thesis
    Read the letter
  • AddedSoitec
    June 2026
    We wrote last quarter that we had increased our position following meetings with management, sensing the fundamentals were closer to turning than the share price implied.
    Read the letter
  • New positionams-OSRAM
    June 2026
    Alongside Soitec and ASML, we have built new positions in ACM Research and ams-OSRAM this quarter, adding to our existing holding in PDF Solutions since launch.
    Read the letter
  • ExitedSanuwave
    June 2026
    I sold with shares down 10% on the day and 30% from purchase.
    Read the letter
  • New positionACM Research
    June 2026
    Alongside Soitec and ASML, we have built new positions in ACM Research and ams-OSRAM this quarter, adding to our existing holding in PDF Solutions since launch.
    Read the letter

Companies held · 11

Every company Goodhart Partners has disclosed a position in across our archive, with the letter that last mentioned it.

Theses · 9

  • June 2026

    ACM Research is held as a mid-cap semiconductor value-chain business with idiosyncratic drivers and less dependence on the semiconductor capex cycle.

    Read the full thesis
  • June 2026

    ams-OSRAM is viewed as a mid-cap semiconductor value-chain business with idiosyncratic drivers and resilience to the broader capex cycle.

    Read the full thesis
  • June 2026

    Bakkafrost is expected to benefit from a Scotland recovery, ending one-off salmon supply pressure, structurally growing salmon demand, and potential El Nino-related supply disruption.

    Read the full thesis
  • Katakura Industries is a deep-value Japanese property and conglomerate play with a fortress balance sheet, valuable assets, and a large discount to NAV.

    Read the full thesis
  • June 2026

    AG Barr is a Scottish drinks company with improving growth ambitions, cost savings from capex, and a low valuation supporting attractive earnings growth.

    Read the full thesis
  • June 2026

    Rheinmetall is a German defense prime with a strong strategic position, benefiting from Germany’s rearmament and an overdone share price sell-off.

    Read the full thesis
  • March 2026

    Bonesupport is an orthobiologics company with a differentiated injectable bioceramic and long-term growth potential at a more acceptable valuation.

    Read the full thesis
  • RaySearch Laboratories is a radiotherapy software company with durable relevance and long-term growth now available at a more attractive price.

    Read the full thesis
  • March 2026

    Diageo is a premium spirits company with attractive long-term emerging-market growth and an appealing valuation.

    Read the full thesis

Letter archive · 8

Funds · 4

  • Goodhart Partners European Fund2
  • Goodhart Partners Global Future Leaders Fund2
  • Goodhart Partners Global Real Return Fund2
  • Goodhart Partners Global Smaller Companies Fund2

Get Goodhart Partners’s next letter the day it lands

We track Goodhart Partners alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.

View plans
Share this fund